GW Pharma to launch first CBD-based epilepsy drug in Europe 'over the next year or two,' CEO says

7:40 PM ET Tue, 24 Sept 2019

"We have 28 countries now in Europe that have approved Epidyolex" to treat epilepsy seizures, GW Pharma CEO Justin Gover says.